Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples.

[1]  Y. Komiyama,et al.  The ratio of plasma to whole-blood serotonin may be a novel marker of atherosclerotic cardiovascular disease. , 2004, The Journal of laboratory and clinical medicine.

[2]  T. Kita,et al.  Munc13-4 Is a GTP-Rab27-binding Protein Regulating Dense Core Granule Secretion in Platelets* , 2004, Journal of Biological Chemistry.

[3]  T. Iwasaka,et al.  High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. , 2004, Clinical biochemistry.

[4]  P. Burger,et al.  Platelets in Inflammation and Thrombosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[5]  R. Flaumenhaft.  Molecular Basis of Platelet Granule Secretion , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[6]  M. Macey,et al.  Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. , 2002, Clinical chemistry.

[7]  K. Horwitz,et al.  Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. , 1994, Circulation.

[8]  V. Kakkar,et al.  Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate acetate. , 1986, The Biochemical journal.

[9]  K. Kaplan,et al.  Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo , 1981 .